Biliary Stents Market Analysis And Forecast To 2031: By Type (Metal Stents, Polymer Stents), By Application (Bilio-pancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), By End-use (Hospitals, Specialty Clinics, Ambulatory Surgica

Biliary Stents Market Analysis And Forecast To 2031: By Type (Metal Stents, Polymer Stents), By Application (Bilio-pancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), By End-use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), And Region

The global biliary stents market was valued at USD 310.2 Million in 2021 and it is anticipated to grow up to USD 610.7 Million by 2031, at a CAGR of 7.0% during the forecast period.

Bile duct is a long tube-like structure that aids in the drainage of bile fluid. Biliary stents, also known as bile duct stents, are employed in disorders causing an obstruction in the bile duct. The bile duct stents are made up of either polymer or metallic materials. Biliary stents are inserted into the duct or lumen to keep the passage open enabling optimum drainage of the biliary fluids. Bile fluids play a major role in food digestion, and it is secreted by liver into intestinal passage through bile duct that opens in intestine.

Market Trends and Drivers

The technological advancements and effective diagnosis procedures have enhanced the accuracy level of ERCP and PTC test. For instance, according to Gastrointestinal Endoscopy Journal, the overall success rate of repeat ERCP procedure is 95%. Furthermore, increasing adoption of minimally invasive procedures are propelling the market demand. Increasing technological advancements associated with the detection and treatment of gastrointestinal disorders, including bile duct obstruction, provide certain benefits such as, shorter hospital stays, lesser chances of infection, and quick recovery. Such factors are boosting the adoption rate of biliary stents contributing to the overall biliary stents market expansion.

Market Restraints and Challenges

The high demand for biliary stents and recurrent stenting procedures increases the total ownership cost of biliary stents. This can potentially hinder the growth of global biliary stents market growth. Polymer stents are mainly composed of Teflon and polyethylene. The market availability of variety of configurations coupled with a relatively lower cost of polymer stents leads to a high demand for the same. However, as the polymer stents need to be replaced faster than its metallic counterparts, the overall cost of treatment associated with it significantly increases. Hence, the limited product lifecycle of polymer stents can potentially hinder the overall biliary stents market expansion.

Global Biliary Stents Market Segmental Overview

The report analyses the global biliary stents market based on type, application, end-user, and region.

Global Biliary Stents Market by Type

By type, the market is segmented into metal stents and polymer stents. The metal stents segment accounted for significant market share in 2021 and is expected to register lucrative CAGR over the forecast period. Metal stents are mesh-like tubes composed of thin wires and are available in wide variety of lengths and diameters. The self-expandable metal stents have a post expansion diameter ranging from 6-10 mm. The major drivers of metal stents include rising incidence of bile duct -related diseases such as biliary leaks, pancreatic cancer, and other malignant obstructions, such as gallstones, leading to blockage of bile duct. The metal stents are noted to offer better patency, minimal slippage post-placement and longer lifecycle. Thus, the demand for metal stents is rapidly increasing, thereby augmenting the market outlook.

Global Biliary Stents Market by Application

By application, the biliary stents market is classified into bilio-pancreatic leakages, pancreatic cancer, benign biliary strictures, gallstones, and others. The gallstones segment accounted for significant revenue in 2021. Lifestyle changes such as adoption of an unhealthy and sedentary lifestyle coupled with a family history of gallstones, are observed to be some of the prominent factors leading to the high prevalence of gallstones. The occurrence of gallstones is termed as non-fatal and one of the most common diseases of the biliary system. For instance, it is estimated that nearly 20 million people in the U.S. i.e., 15% of the country’s population have gallstones. As these tend to create blockages in the biliary tract, an optimum management of gallstones is very essential. Hence, this leads to the increasing adoption of biliary stents, thereby fostering the industry growth.

The end-use segment of the market is bifurcated into hospitals, specialty clinics, ambulatory surgical centres, and others. The ambulatory surgical centres are expected to register highest CAGR between 2022 and 2028. With several advantages of ambulatory care such as lowered costs, quick recovery as well as lower rates of infection coupled with the rising preference towards minimally invasive procedures, the segment is witnessing a higher demand in developed and some parts of the developing countries. Additionally, increasing adoption of biliary stents and related procedures requires minimal risk of complications to attract a wider customer base. Hence, factors such as increased adoption of minimally invasive procedures and increased healthcare expenditure are noted to drive the segment demand.

Geographical Analysis of Global Biliary Stents Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America biliary stents market revenue is poised to grow significant CAGR during the forthcoming years. This can be attributed to the increasing geriatric population susceptible to diseases such as pancreatic cancer, gallstones, and other malignant obstructions are some of the major factors that will drive the regional market size. Moreover, increasing awareness of advanced technology for the diagnosis and treatment will favor the North America biliary stents industry forecasts.

Major Players in the Global Biliary Stents Market

The key players in the biliary stents market

COVID-19 Impact

The outbreak of COVID-19 pandemic had a negative impact on the biliary stents market as the pandemic was noted to have disrupted the healthcare system worldwide, causing significant delays in surgeries, treatment, and diagnosis of non-emergency disease conditions. With the increasing number of COVID-19 cases, several local and national regulatory bodies-imposed lockdowns, restricting the movement of people and goods. The imposed lockdowns largely affected the company’s operations while also hindering the overall market’s supply chain, resulting in the delayed and limited supply of biliary stents to end users. The significant impact of pandemic on the product delivery is also estimated to have potentially resulted in a decline in bile duct cancer care and hampered the industry growth in the initial months of the COVID-19 pandemic. Several cases also established a link between corona virus infection and a subsequent liver injury that resulted as a major complication. Hence, it is estimated to have an optimistic impact on the global market as the restrictions are eased down

Recent Developments

• In September 2021, B. Braun launched CARESAFE™ IV administration sets with Optional AirStop
• In October 2021, Boston Scientific announced that it has received the 510 (k) U.S. Food and Drug Administration clearance and CE Mark approval to market its Advanix biliary plastic stents. The approval will enhance the company’s product portfolio, thus increase the revenue of the company.
• In October 2020, Olympus Corporation launched of VorticCatchV EndoTherapy and StoneMasterV device. These devices offer better patient outcome and promote procedural efficiency, further facilitating efficient bile duct stone management and retrieval for ERCP procedure. The product launch was aimed at expanding the company’s product offering as well as enhance its market presence.

Frequently Asked Questions

Q1. How big is the biliary stents market?Ans. The global biliary stents market size was USD 310.2 Million in 2021 and is anticipated to reach USD 610.7 Million in 2031, growing at a rate of 7.0% from 2022 to 2031.Q2. What is the biliary stents market growth rate?Ans. The growth rate of the biliary stents market is 7.0%Q3. Which region holds a major market share for the market?Ans. North America holds a major market share of the biliary stents market in 2021.Q4. Which segment accounted for the largest biliary stents market share?Ans. By end-user, the hospital segment accounted for the largest biliary stents market share.Q5. Who are the key players in the kidney stones management market?Ans. The global biliary stents market report includes players such as Q6. What are the factors driving the biliary stents market growth?Ans. The major factors driving the growth of the market are increasing prevalence of bile duct and chronic liver disease coupled with adoption of minimally invasive approach to boosts the stents marketQ7. What are the key growth strategies of biliary stents market players?Ans. The key growth strategies of biliary stents market players are product launch and product approval.Q8. Which region will provide more business opportunities for the biliary stents market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the biliary stents market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.